Avant Immunotherapeutics Company Profile

13:25 EDT 18th September 2018 | BioPortfolio

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the company is conducting clinical studies of a proprietary vaccine candidate for cholesterol management. AVANT further leverages the value of its technology portfolio through corporate partnerships. Current collaborations encompass the development of an oral human rotavirus vaccine, vaccines to combat threats of biological warfare, and vaccines addressed to human food safety and animal health.


119 Fourth Avenue
United States of America


Phone: 781 433 0771
Fax: 781 433 0262

News Articles [100 Associated News Articles listed on BioPortfolio]

INFECTIONS NOSOCOMIALES : Et si l’on s’attaquait à leur persistance ?

Au sein des populations bactériennes, certaines cellules réparent l'ADN endommagé avant de reprendre leur croissance, et d'autres reprennent leur croissance avant de faire des réparation...

Neurology diagnostic assets from Avant reaquired by Amarantus

The LymPro Test, MSPrecise and NuroPro neurology diagnostic tests were reacquired by Amarantus Bioscience from Avant Diagnost -More- 

Boehringer and OSE Immunotherapeutics to develop new cancer drug

Boehringer Ingelheim has formed an alliance with OSE Immunotherapeutics to develop a SIRP-alpha antagonist compound to treat advanced solid tumours....Read More... The post Boehringer and OSE Immunoth...

ESCARRE : Le pansement qui repère l’ulcère avant l’infirmière

Nouveau pansement ou prototype intelligent qui promet de repérer les ulcères de pression avant qu'elles ne soient visibles par les médecins ou les soignants. Ce développement de l’Universit...

OSE Immunotherapeutics And Servier Join Forces In Auto-Immune Field

French groups OSE Immunotherapeutics and Servier have inked a pact to develop and commercialize the newly formed biotech's interleukin-7 antagonist...   

Boehringer, OSE Immunotherapeutics sign $1.4bn immuno-oncology deal

Boehringer Ingelheim has entered into an exclusive worldwide collaboration and license agreement with OSE Immunotherapeutics for the development of a new checkpoint inhibitor to treat solid tumors.

OSE Immunotherapeutics Receives a €435,000 Translational Research Grant to Develop Precision Medicine Targeting for Tedopi

Funding through the Eurostars European Programme, led in France by Bpifrance Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) (Paris:OSE) today announces that the Compan...

SCLÉROSE en PLAQUES : La maladie a son prodrome, 5 ans avant le diagnostic

Une constellation de symptômes présage les tout débuts de la sclérose en plaques (SEP), révèle cette étude de l’University of British Columbia (Canada), le plus gros effort jamais réalisé p...

Drugs and Medications [16 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

Banana boat sport spf 60 [Accra-Pac, Inc.]

Banana Boat Sport SPF 60

PubMed Articles [93 Associated PubMed Articles listed on BioPortfolio]

Recent developments with immunotherapy for hepatocellular carcinoma.

Immunotherapy is on the way to become the new standard of care for advanced hepatocellular carcinoma (HCC) worldwide. With higher rates of objective responses, and overall less side effects compared t...

Human Vaccines & Immunotherapeutics: News.

Human Vaccines & Immunotherapeutics: News.

Human Vaccines & Immunotherapeutics: News.

Human Vaccines & Immunotherapeutics: News.

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Cabozantinib in Combination With Durvalumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies (CAMILLA)

The investigators propose to evaluate cabozantinib in combination with durvalumab in previously treated patients with advanced gastroesophageal cancer and other gastrointestinal (GI) malig...

AVANT, DUAKLIR Study to Patients With Stable COPD to Assess the Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate

This is a multiple dose, randomised, parallel, double blind, double dummy, multicentre and multinational Phase III study to determine the efficacy and safety of Aclidinium bromide/Formoter...

Personalized Immunotherapeutics for Antibiotic-resistant Infection

M. A. suffers from hypogammaglobulinemia that has been complicated by refractory Mycoplasma hominis septic arthritis. He has been receiving the antibiotic valnemulin under Emergency Invest...

35RC17_8826_NEPHROPAIN Phase APRES : Interest of the Equimolar Oxygen Nitride Mixture (MEOPA) in the Treatment of Pain in Patients Presenting to the Emergency Department for Suspected Renal Colic: a Study BEFORE AFTER

MEOPA (Equimolar Oxygen-Nitrogen Protoxide Mix) is a gas used in emergencies for short-term painful acts. It is often very effective with an analgesic, anxiolytic and muscle relaxant actio...

Companies [28 Associated Companies listed on BioPortfolio]

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...

MedRx Inc

Largo, Florida - April 11, 2006 – MedRx, Inc introduces the AVANT Mobile Office which provides a computerized testing and fitting system which is extremely portable for the traveling profession...

Avant Diagnostics, Inc.

Avant Diagnostics, Inc. is a medical diagnostic technology company that specializes in large panel biomarker screening. Our first test, OvaDx®, developed in conjunction with Ar...

Innate Immunotherapeutics Limited

Innate Immunotherapeutics Limited is a public unlisted biopharmaceutical company based in Auckland, New Zealand. The company is focused on the development of a new generation of i...

Avant Healthcare Marketing

More Information about "Avant Immunotherapeutics" on BioPortfolio

We have published hundreds of Avant Immunotherapeutics news stories on BioPortfolio along with dozens of Avant Immunotherapeutics Clinical Trials and PubMed Articles about Avant Immunotherapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Avant Immunotherapeutics Companies in our database. You can also find out about relevant Avant Immunotherapeutics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record